Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Intraductal proliferative lesions of the breast-terminology and biology matter: premalignant lesions or preinvasive cancer?

Costarelli L, Campagna D, Mauri M, Fortunato L.

Int J Surg Oncol. 2012;2012:501904. doi: 10.1155/2012/501904. Epub 2012 May 10.

2.

Assessment of lesions coexisting with various grades of ductal intraepithelial neoplasia of the breast.

Bratthauer GL, Tavassoli FA.

Virchows Arch. 2004 Apr;444(4):340-4. Epub 2004 Feb 19.

PMID:
14986131
3.

Premalignant and in situ breast disease: biology and clinical implications.

Arpino G, Laucirica R, Elledge RM.

Ann Intern Med. 2005 Sep 20;143(6):446-57.

PMID:
16172443
4.

Morphologic and molecular evolutionary pathways of low nuclear grade invasive breast cancers and their putative precursor lesions: further evidence to support the concept of low nuclear grade breast neoplasia family.

Abdel-Fatah TM, Powe DG, Hodi Z, Reis-Filho JS, Lee AH, Ellis IO.

Am J Surg Pathol. 2008 Apr;32(4):513-23. doi: 10.1097/PAS.0b013e318161d1a5.

PMID:
18223478
5.

[Classification of preinvasive breast and carcinoma in situ: doubts, controversies, and proposal for new categorizations].

Dauplat MM, Penault-Llorca F.

Bull Cancer. 2004 Dec 1;91 Suppl 4:S205-10. Review. French.

PMID:
15899609
6.
7.
8.

Intraductal proliferative lesions of the breast: morphology, associated risk and molecular biology.

Ellis IO.

Mod Pathol. 2010 May;23 Suppl 2:S1-7. doi: 10.1038/modpathol.2010.56. Review.

9.
10.

Stereotaxic fine needle aspiration cytology of clinically occult malignant and premalignant breast lesions.

Bibbo M, Scheiber M, Cajulis R, Keebler CM, Wied GL, Dowlatshahi K.

Acta Cytol. 1988 Mar-Apr;32(2):193-201. Erratum in: Acta Cytol 1992 May-Jun;36(3):460.

PMID:
2831687
11.

Why the term 'low-grade ductal carcinoma in situ' should be changed to 'borderline breast disease': diagnostic and clinical implications.

Masood S.

Womens Health (Lond Engl). 2012 Jan;8(1):57-62. doi: 10.2217/whe.11.88. Review.

PMID:
22171775
12.

Borderline breast lesions: diagnostic challenges and clinical implications.

Masood S, Rosa M.

Adv Anat Pathol. 2011 May;18(3):190-8. doi: 10.1097/PAP.0b013e31821698cc. Review.

PMID:
21490436
13.

Combined E-cadherin and high molecular weight cytokeratin immunoprofile differentiates lobular, ductal, and hybrid mammary intraepithelial neoplasias.

Bratthauer GL, Moinfar F, Stamatakos MD, Mezzetti TP, Shekitka KM, Man YG, Tavassoli FA.

Hum Pathol. 2002 Jun;33(6):620-7.

PMID:
12152161
14.
15.

Different proliferative patterns characterize different preinvasive breast lesions.

Viacava P, Naccarato AG, Bevilacqua G.

J Pathol. 1999 Jul;188(3):245-51.

PMID:
10419590
16.

Usual ductal hyperplasia of the breast is a committed stem (progenitor) cell lesion distinct from atypical ductal hyperplasia and ductal carcinoma in situ.

Boecker W, Moll R, Dervan P, Buerger H, Poremba C, Diallo RI, Herbst H, Schmidt A, Lerch MM, Buchwalow IB.

J Pathol. 2002 Dec;198(4):458-67.

PMID:
12434415
17.
18.
19.

Flat epithelial atypia of the breast.

Lerwill MF.

Arch Pathol Lab Med. 2008 Apr;132(4):615-21. doi: 10.1043/1543-2165(2008)132[615:FEAOTB]2.0.CO;2. Review.

PMID:
18384213
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk